Search
Selected: All

2-methyl-3-butenyl-1-pyrophosphoric acid salts and agents...

Drug – bio-affecting and body treating compositions – Lymphokine – Interleukin
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Adjuvant compositions for vaccines

Drug – bio-affecting and body treating compositions – Lymphokine – Interleukin
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Administration of acemannan

Drug – bio-affecting and body treating compositions – Lymphokine – Interleukin
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Administration of non-glycosylated, recombinant human IL.sub.2 i

Drug – bio-affecting and body treating compositions – Lymphokine – Interleukin
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Agent for potentiating the effect of interleukin-8

Drug – bio-affecting and body treating compositions – Lymphokine – Interleukin
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Antagonists of interleukin-15

Drug – bio-affecting and body treating compositions – Lymphokine – Interleukin
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Anti-endotoxin, interleukin-1 receptor antagonist and anti-tumor

Drug – bio-affecting and body treating compositions – Lymphokine – Interleukin
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Anti-inflammatory compositions and methods

Drug – bio-affecting and body treating compositions – Lymphokine – Interleukin
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Anti-inflammatory compositions and methods

Drug – bio-affecting and body treating compositions – Lymphokine – Interleukin
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Antitumoral composition based on polypeptides having human inter

Drug – bio-affecting and body treating compositions – Lymphokine – Interleukin
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Avian cytokines, such as IL-12, comprising a p40 and/or p35...

Drug – bio-affecting and body treating compositions – Lymphokine – Interleukin
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Avian cytokines, such as IL-12, comprising a p40 and/or p35...

Drug – bio-affecting and body treating compositions – Lymphokine – Interleukin
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Biological applications of new peptides of IL-2 and...

Drug – bio-affecting and body treating compositions – Lymphokine – Interleukin
Utility Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Bovine interleukin-1.alpha.

Drug – bio-affecting and body treating compositions – Lymphokine – Interleukin
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

C-reactive protein fragment with immunomodulatory activity

Drug – bio-affecting and body treating compositions – Lymphokine – Interleukin
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Cancer therapy using interleukin-2 and flavone compounds

Drug – bio-affecting and body treating compositions – Lymphokine – Interleukin
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Cancer treatment combining lymphodepleting agent with CTLs...

Drug – bio-affecting and body treating compositions – Lymphokine – Interleukin
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Cancer treatments including administering IL-2 fusion...

Drug – bio-affecting and body treating compositions – Lymphokine – Interleukin
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Canine IL-4 immunoregulatory proteins and uses thereof

Drug – bio-affecting and body treating compositions – Lymphokine – Interleukin
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Canine IL-4 immunoregulatory proteins and uses thereof

Drug – bio-affecting and body treating compositions – Lymphokine – Interleukin
Reissue Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0
  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.